Attached files

file filename
EX-99.1 - EX-99.1 - AFFYMETRIX INCex99-1.htm

 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549

FORM 8-K
  
CURRENT REPORT
  
Pursuant to Section 13 or 15(d) of the
 
Securities Exchange Act of 1934
  
Date of Report (Date of earliest event reported): March 22, 2013
   
AFFYMETRIX, INC.
 
(Exact name of registrant as specified in its charter)
 
DELAWARE
 
0-28218
 
77-0319159
(State of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
3420 Central Expressway
 
Santa Clara, California 95051
 
(Address of principal executive offices) (Zip Code)
   
(408) 731-5000
 
Registrant's telephone number, including area code
  
(Former name or former address, if changed since last report.)
 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
   
 
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))

Item 7.01 Regulation FD Disclosure

On March 22, 2013, Affymetrix, Inc. issued a press release announcing it entered into a contract with UK Biobank to genotype 500,000 DNA samples.

The information set forth in this Item 7.01 of Form 8-K is furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, expect as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Exhibit No.
 
Description
 
 
 
99.1
 
Press Release dated March 22, 2013



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
   
 
AFFYMETRIX, INC.
 
 
 
 
 
By:
/s/ John F. Runkel, Jr.
 
 
Name:
John F. Runkel, Jr.
 
 
Title:
Executive Vice President, General Counsel
 
 
 
and Secretary
 

Dated: March 22, 2013